Class III
Ongoing
Tobramycin Opthalmic Solution USP, 0.3%, 5mL bottle, Rx only, Manufactured for: Alembic Pharmaceuticals, Bedminster, NJ 07921, USA, NDC 62332-518-05
This recall is currently active, issued August 23, 2023. It was issued by Alembic Pharmaceuticals, Inc..
- Company
- Alembic Pharmaceuticals, Inc.
- Recall Initiated
- July 27, 2023
- Posted
- August 23, 2023
- Recall Number
- D-1086-2023
- Voluntary / Mandated
- Voluntary: Firm initiated
- Quantity
- 82,400 bottles
- Firm Location
- Bedminster, NJ, United States
- Official Source
- View on FDA website ↗
Reason for Recall
Failed Impurities/Degradation Specifications
Distribution
Nationwide in the USA
Lot / Code Info
Lot #: AMR103, Exp: 10/2023; Lot#: AMR201, Exp: 06/2024
More recalls by Alembic Pharmaceuticals, Inc.
Other recent Class III Drug recalls
Eptifibatide Injection, 75 mg/100 mL vial for weight-adjusted bolus dosing, 1x100 mL Single-dose Via...
Slate Run Pharmaceuticals
· Mar 4, 2026
Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceutica...
Unichem Pharmaceuticals Usa Inc.
· Feb 18, 2026
parodontax (cetylpyridinium chloride)ACTIVE GUM HEALTH, Mouthwash, Mint. Net Wt 16.9 FL OZ (500 mL),...
Haleon Us Holdings Llc
· Feb 4, 2026
Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN Pharmaceutic...
Novadoz Pharmaceuticals Llc
· Feb 4, 2026
Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd.,...
Cipla Usa, Inc.
· Jan 28, 2026